These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7658448)

  • 1. Selective inhibitors of Candida albicans dihydrofolate reductase: activity and selectivity of 5-(arylthio)-2,4-diaminoquinazolines.
    Chan JH; Hong JS; Kuyper LF; Baccanari DP; Joyner SS; Tansik RL; Boytos CM; Rudolph SK
    J Med Chem; 1995 Sep; 38(18):3608-16. PubMed ID: 7658448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations.
    Gokhale VM; Kulkarni VM
    J Comput Aided Mol Des; 2000 Jul; 14(5):495-506. PubMed ID: 10896321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A; Papoulis AT; Forsch RA; Queener SF
    J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
    J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen
    DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
    Rosowsky A; Hynes JB; Queener SF
    Antimicrob Agents Chemother; 1995 Jan; 39(1):79-86. PubMed ID: 7695334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor.
    Whitlow M; Howard AJ; Stewart D; Hardman KD; Chan JH; Baccanari DP; Tansik RL; Hong JS; Kuyper LF
    J Med Chem; 2001 Aug; 44(18):2928-32. PubMed ID: 11520201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro biological activity and structural analysis of 2,4-diamino-5-(2'-arylpropargyl)pyrimidine inhibitors of Candida albicans.
    Paulsen JL; Liu J; Bolstad DB; Smith AE; Priestley ND; Wright DL; Anderson AC
    Bioorg Med Chem; 2009 Jul; 17(14):4866-72. PubMed ID: 19560363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines.
    Sirawaraporn W; Sertsrivanich R; Booth RG; Hansch C; Neal RA; Santi DV
    Mol Biochem Parasitol; 1988 Oct; 31(1):79-85. PubMed ID: 3185614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.
    Kuyper LF; Baccanari DP; Jones ML; Hunter RN; Tansik RL; Joyner SS; Boytos CM; Rudolph SK; Knick V; Wilson HR; Caddell JM; Friedman HS; Comley JC; Stables JN
    J Med Chem; 1996 Feb; 39(4):892-903. PubMed ID: 8632413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The toxicity of antifolates in Babesia bovis.
    Nott SE; Bagnara AS
    Int J Parasitol; 1993 May; 23(3):399-402. PubMed ID: 8359989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
    Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.
    Gangjee A; Zhu Y; Queener SF
    J Med Chem; 1998 Nov; 41(23):4533-41. PubMed ID: 9804692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of Candida albicans dihydrofolate reductase bound to propargyl-linked antifolates reveal the flexibility of active site loop residues critical for ligand potency and selectivity.
    Paulsen JL; Bendel SD; Anderson AC
    Chem Biol Drug Des; 2011 Oct; 78(4):505-12. PubMed ID: 21726415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines.
    Lam T; Hilgers MT; Cunningham ML; Kwan BP; Nelson KJ; Brown-Driver V; Ong V; Trzoss M; Hough G; Shaw KJ; Finn J
    J Med Chem; 2014 Feb; 57(3):651-68. PubMed ID: 24428639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
    Otzen T; Wempe EG; Kunz B; Bartels R; Lehwark-Yvetot G; Hänsel W; Schaper KJ; Seydel JK
    J Med Chem; 2004 Jan; 47(1):240-53. PubMed ID: 14695838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
    Rosowsky A; Mota CE; Queener SF; Waltham M; Ercikan-Abali E; Bertino JR
    J Med Chem; 1995 Mar; 38(5):745-52. PubMed ID: 7877140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,4-Diamino-5-chloroquinazoline analogues of trimetrexate and piritrexim: synthesis and antifolate activity.
    Rosowsky A; Mota CE; Wright JE; Queener SF
    J Med Chem; 1994 Dec; 37(26):4522-8. PubMed ID: 7799402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.